CE InformationCourse Progress
  • Access Webinar
  • Evaluation
  • Download PDF of Slides
  • Certificate
Evaluation

Addressing the Complexities of Vitiligo: Targeted Strategies to Improve Quality of Life

Evaluation

HMP Education would appreciate your feedback on the quality and impact of this activity.

Please answer the following questions, some of which include a 5-point Likert scale (5 = strongly agree/excellent/great deal; 1 = strongly disagree/poor/very little).

To what extent are you able to better achieve each of the following learning objectives?

Outline the prevalence, impact, and disease burden of vitiligo
Describe the significance of the JAK-STAT pathway in vitiligo
Evaluate newer and emerging treatments and recommended protocols for segmental and nonsegmental vitiligo
Integrate strategies to optimize multidisciplinary care team efforts to care for patients with vitiligo

Please rate the faculty on the following:

Seemal Desai, MD: Knowledge, expertise, and teaching ability

Please rate the following components relating to this activity:

Content
Relevance to your practice 
Educational format 
Audience-participation portions (eg., Q&A, polling, pre/post-testing) 
Resources and/or other materials supporting the activity
Overall

Therapeutic recommendations presented in this activity did not encourage inappropriate or excessive use of products/devices.

How many patients with Vitiligo do you see during a typical week? 

Do you feel like there were any new data presented?

Did you learn anything new?

Did you gain confidence on the new information?

Did this program include opportunities to learn as a part of a healthcare team?
In the US, approximately what percentage of individuals with vitiligo are estimated to be undiagnosed?
Which of the following cytokines is involved in JAK/STAT initiation and contributes to vitiligo pathophysiology?
In two phase 2 trials, which of the following demonstrated improved repigmentation of nonsegmental vitiligo lesions through 52 weeks of follow-up?
How confident are you now in your ability to implement strategies to improve recognition and optimal multidisciplinary care for vitiligo management?

Do you intend to make any additional changes to your practice as a result of information gained from this activity? Please be specific.
What challenges or barriers outside of your control may prevent you from changing your practice?
255 characters max

The information presented in this activity did not serve to advance a proprietary interest of any commercial entity.
Based on my participation in this activity, I anticipate I will more often: (select all that apply)